Home / HLTRF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does HLTRF make money? Does HLTRF have pricing power? What's the Earnings Whisper? Will HLTRF profit more as the business scales? What is HLTRF's management track record? Is HLTRF's current price justified?

HLS Therapeutics Inc.

$2.82 -$0.61 (-17.78%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$2.64

Day Range

$2.82 - $2.82

Year Range

$2.64$4.02

Market Cap

88.2M

AVG Volume

486

Trailing/Forward PE

-10.61/-

PEG ratio

0.16

Dividend Yield

Next Earnings Date

2026-11-12

Primary Exchange

Other OTC

Revenue (USD)

HLTRF Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	14.67M
26 Q1	12.69M
25 Q4	15.43M
25 Q3	13.51M
25 Q2	14.17M
25 Q1	12.62M
24 Q4	15.54M
24 Q3	14.09M
24 Q2	14.52M
24 Q1	12.42M

Net Income (USD)

HLTRF Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	-1.02M
26 Q1	-2.27M
25 Q4	-1.36M
25 Q3	-3.92M
25 Q2	-2.74M
25 Q1	-4.44M
24 Q4	-3.02M
24 Q3	-4.84M
24 Q2	-5.68M
24 Q1	-6.08M

Operating Income (USD)

HLTRF Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-1.16M
26 Q1	-2.18M
25 Q4	240.64K
25 Q3	-1.37M
25 Q2	-778K
25 Q1	-2.19M
24 Q4	-3.04M
24 Q3	-5.02M
24 Q2	3.83M
24 Q1	-3.45M

EBITDA (USD)

HLTRF EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	5.27M
26 Q1	3.27M
25 Q4	5.79M
25 Q3	4.02M
25 Q2	4.72M
25 Q1	2.92M
24 Q4	4.79M
24 Q3	3.06M
24 Q2	6.96M
24 Q1	2.4M

Cash Flows (USD)

HLTRF Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	2.84M
26 Q1	6.28M
25 Q4	6.41M
25 Q3	2.2M
25 Q2	3.52M
25 Q1	3.52M
24 Q4	3.19M
24 Q3	1.5M
24 Q2	2.52M
24 Q1	241.91K

EPS (USD)

HLTRF EPS (USD) by quarter
Period	EPS (USD)
26 Q2	-0.03
26 Q1	-0.07
25 Q4	-0.04
25 Q3	-0.12
25 Q2	-0.09
25 Q1	-0.14
24 Q4	-0.09
24 Q3	-0.15
24 Q2	-0.18
24 Q1	-0.19

Expenses (USD)

HLTRF Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	5.81M
26 Q1	5.35M
25 Q4	5.25M
25 Q3	5.84M
25 Q2	6.68M
25 Q1	5.64M
24 Q4	6.2M
24 Q3	6.8M
24 Q2	6.97M
24 Q1	6.98M

Cash & Debt (USD)

HLTRF Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	13.73M
26 Q1	12.37M
25 Q4	11.7M
25 Q3	10.78M
25 Q2	12.15M
25 Q1	17.73M
24 Q4	17.46M
24 Q3	17.54M
24 Q2	32.51M
24 Q1	19.42M

Debt ratios

HLTRF Debt ratios by quarter
Period	Debt ratios
26 Q2	1.54
26 Q1	1.78
25 Q4	2.18
25 Q3	2.63
25 Q2	2.8
25 Q1	2.6
24 Q4	2.85
24 Q3	3.12
24 Q2	3.09
24 Q1	6.25

Margins

HLTRF Margins by quarter
Period	Margins
26 Q2	80.56%
26 Q1	36.12%
25 Q4	46.65%
25 Q3	81.22%
25 Q2	82.32%
25 Q1	81%
24 Q4	82.72%
24 Q3	84.13%
24 Q2	43.8%
24 Q1	38.32%

Return on Capital

HLTRF Return on Capital by quarter
Period	Return on Capital
26 Q2	-1.85%
26 Q1	-3.85%
25 Q4	-2.2%
25 Q3	-6.35%
25 Q2	-4.12%
25 Q1	-6.64%
24 Q4	-4.24%
24 Q3	-6.11%
24 Q2	-6.87%
24 Q1	-6.83%

Shares Outstanding

HLTRF Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	34M
26 Q1	31.27M
25 Q4	31.27M
25 Q3	31.4M
25 Q2	31.64M
25 Q1	31.79M
24 Q4	31.79M
24 Q3	31.79M
24 Q2	31.83M
24 Q1	31.94M

Dividends (USD)

HLTRF Dividends (USD) by quarter
Period	Dividends (USD)
Apr 23	0.04
Jan 23	0.04
Oct 22	0.04
Jul 22	0.04
Apr 22	0.04
Jan 22	0.04
Oct 21	0.04
Jul 21	0.04
Apr 21	0.04
Jan 21	0.04

Book Value Per Share (USD)

HLTRF Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	1.62
26 Q1	1.88
25 Q4	1.97
25 Q3	1.97
25 Q2	2.1
25 Q1	2.1
24 Q4	2.24
24 Q3	2.5
24 Q2	2.6
24 Q1	2.79

Total Assets (USD)

HLTRF Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	128.55M
26 Q1	131.52M
25 Q4	137.28M
25 Q3	140.23M
25 Q2	149.07M
25 Q1	153.95M
24 Q4	159.9M
24 Q3	171.74M
24 Q2	191.29M
24 Q1	197.55M

Free Cash Flow Yield

HLTRF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	20.87%
Sep 26	22.29%
Aug 26	21.32%
Aug 26	21.4%
Aug 26	21.17%
Aug 26	19.75%
Jul 26	19.75%
Jul 26	19.61%
Jul 26	19.04%
Jul 26	19.04%
Jul 26	19.61%
Jun 26	15.83%
Jun 26	15.83%
Jun 26	15.88%
Jun 26	15.88%
May 26	15.35%
May 26	15.35%
May 26	14.63%
May 26	14.63%
May 26	14.54%
Apr 26	14.71%
Apr 26	14.8%
Apr 26	15.59%
Apr 26	16.68%
Mar 26	13.19%
Mar 26	11.78%
Mar 26	11.78%
Mar 26	11.78%
Feb 26	11.78%
Feb 26	11.78%
Feb 26	11.78%
Feb 26	11.78%
Jan 26	11.78%
Jan 26	11.78%
Jan 26	11.78%
Jan 26	11.78%
Jan 26	11.54%
Dec 25	10.78%
Dec 25	10.84%
Dec 25	10.84%
Dec 25	10.69%
Nov 25	10.69%
Nov 25	10.69%
Nov 25	10.69%
Nov 25	9.22%
Oct 25	9.22%
Oct 25	9.22%
Oct 25	9.22%
Oct 25	9.22%
Oct 25	9.76%
Sep 25	8.88%
Sep 25	8.82%
Sep 25	8.82%
Sep 25	8.88%
Aug 25	8.88%
Aug 25	8.88%
Aug 25	9%
Aug 25	9.15%
Aug 25	9.12%
Jul 25	9.46%
Jul 25	9.1%
Jul 25	9.1%
Jul 25	9.22%
Jun 25	6.41%
Jun 25	6.41%
Jun 25	6.41%
Jun 25	6.41%
May 25	7.28%
May 25	7.28%
May 25	7.28%
May 25	7.28%
May 25	6.82%
Apr 25	7.82%
Apr 25	7.92%
Apr 25	7.92%
Apr 25	7.13%
Mar 25	7.81%
Mar 25	7.76%
Mar 25	9.3%
Mar 25	8.73%
Feb 25	8.61%
Feb 25	8.61%
Feb 25	9.3%
Feb 25	9.3%
Jan 25	9%
Jan 25	9%
Jan 25	9.77%
Jan 25	9.23%
Jan 25	9.23%
Dec 24	13.89%
Dec 24	14.77%
Dec 24	15.57%
Dec 24	15.84%
Nov 24	14.38%
Nov 24	15.38%
Nov 24	15.7%
Nov 24	13.69%
Nov 24	14.95%
Oct 24	15.77%
Oct 24	13.16%

Price to Sales

HLTRF Price to Sales by quarter
Period	Price to Sales
Sep 26	1.58
Sep 26	1.48
Aug 26	1.55
Aug 26	1.54
Aug 26	1.56
Aug 26	1.67
Jul 26	1.67
Jul 26	1.68
Jul 26	1.73
Jul 26	1.73
Jul 26	1.68
Jun 26	1.77
Jun 26	1.77
Jun 26	1.77
Jun 26	1.77
May 26	1.83
May 26	1.83
May 26	1.92
May 26	1.92
May 26	1.93
Apr 26	1.91
Apr 26	1.9
Apr 26	1.8
Apr 26	1.68
Mar 26	1.69
Mar 26	1.89
Mar 26	1.89
Mar 26	1.89
Feb 26	1.89
Feb 26	1.89
Feb 26	1.89
Feb 26	1.89
Jan 26	1.89
Jan 26	1.89
Jan 26	1.89
Jan 26	1.89
Jan 26	1.93
Dec 25	1.93
Dec 25	1.92
Dec 25	1.92
Dec 25	1.95
Nov 25	1.95
Nov 25	1.95
Nov 25	1.95
Nov 25	2.25
Oct 25	2.25
Oct 25	2.25
Oct 25	2.25
Oct 25	2.25
Oct 25	2.13
Sep 25	2.13
Sep 25	2.15
Sep 25	2.15
Sep 25	2.13
Aug 25	2.13
Aug 25	2.13
Aug 25	2.1
Aug 25	2.07
Aug 25	2.07
Jul 25	2
Jul 25	2.08
Jul 25	2.08
Jul 25	2.05
Jun 25	2.06
Jun 25	2.06
Jun 25	2.06
Jun 25	2.06
May 25	1.81
May 25	1.81
May 25	1.81
May 25	1.81
May 25	1.93
Apr 25	1.69
Apr 25	1.66
Apr 25	1.66
Apr 25	1.85
Mar 25	1.8
Mar 25	1.81
Mar 25	1.51
Mar 25	1.61
Feb 25	1.64
Feb 25	1.64
Feb 25	1.51
Feb 25	1.51
Jan 25	1.56
Jan 25	1.56
Jan 25	1.44
Jan 25	1.53
Jan 25	1.53
Dec 24	1.44
Dec 24	1.36
Dec 24	1.29
Dec 24	1.27
Nov 24	1.4
Nov 24	1.31
Nov 24	1.28
Nov 24	1.47
Nov 24	1.34
Oct 24	1.27
Oct 24	1.53

EV/EBITDA

HLTRF EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	6.74
Sep 26	6.42
Aug 26	6.63
Aug 26	6.61
Aug 26	6.67
Aug 26	7.02
Jul 26	7.02
Jul 26	7.05
Jul 26	7.21
Jul 26	7.21
Jul 26	7.05
Jun 26	7.85
Jun 26	7.85
Jun 26	7.83
Jun 26	7.83
May 26	8.02
May 26	8.02
May 26	8.31
May 26	8.31
May 26	8.35
Apr 26	8.28
Apr 26	8.24
Apr 26	7.93
Apr 26	7.56
Mar 26	8.36
Mar 26	9.05
Mar 26	9.05
Mar 26	9.05
Feb 26	9.05
Feb 26	9.05
Feb 26	9.05
Feb 26	9.05
Jan 26	9.05
Jan 26	9.05
Jan 26	9.05
Jan 26	9.05
Jan 26	9.18
Dec 25	9.83
Dec 25	9.79
Dec 25	9.79
Dec 25	9.89
Nov 25	9.89
Nov 25	9.89
Nov 25	9.89
Nov 25	11.02
Oct 25	11.02
Oct 25	11.02
Oct 25	11.02
Oct 25	11.02
Oct 25	10.57
Sep 25	9.41
Sep 25	9.46
Sep 25	9.46
Sep 25	9.41
Aug 25	9.41
Aug 25	9.41
Aug 25	9.32
Aug 25	9.21
Aug 25	9.23
Jul 25	9
Jul 25	9.25
Jul 25	9.25
Jul 25	9.16
Jun 25	9.61
Jun 25	9.61
Jun 25	9.61
Jun 25	9.61
May 25	8.8
May 25	8.8
May 25	8.8
May 25	8.8
May 25	9.2
Apr 25	8.39
Apr 25	8.32
Apr 25	8.32
Apr 25	8.93
Mar 25	9.44
Mar 25	9.48
Mar 25	8.43
Mar 25	8.78
Feb 25	8.86
Feb 25	8.86
Feb 25	8.43
Feb 25	8.43
Jan 25	8.61
Jan 25	8.61
Jan 25	8.18
Jan 25	8.47
Jan 25	8.47
Dec 24	8.32
Dec 24	8.01
Dec 24	7.76
Dec 24	7.68
Nov 24	8.15
Nov 24	7.82
Nov 24	7.72
Nov 24	8.4
Nov 24	7.95
Oct 24	7.7
Oct 24	8.62

Price/Operating Cashflow

HLTRF Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 26	4.45
Sep 26	4.17
Aug 26	4.36
Aug 26	4.34
Aug 26	4.39
Aug 26	4.71
Jul 26	4.71
Jul 26	4.74
Jul 26	4.88
Jul 26	4.88
Jul 26	4.74
Jun 26	5.79
Jun 26	5.79
Jun 26	5.77
Jun 26	5.77
May 26	5.97
May 26	5.97
May 26	6.27
May 26	6.27
May 26	6.3
Apr 26	6.23
Apr 26	6.19
Apr 26	5.88
Apr 26	5.5
Mar 26	6.81
Mar 26	7.63
Mar 26	7.63
Mar 26	7.63
Feb 26	7.63
Feb 26	7.63
Feb 26	7.63
Feb 26	7.63
Jan 26	7.63
Jan 26	7.63
Jan 26	7.63
Jan 26	7.63
Jan 26	7.79
Dec 25	8.47
Dec 25	8.42
Dec 25	8.42
Dec 25	8.54
Nov 25	8.54
Nov 25	8.54
Nov 25	8.54
Nov 25	9.9
Oct 25	9.9
Oct 25	9.9
Oct 25	9.9
Oct 25	9.9
Oct 25	9.35
Sep 25	11.22
Sep 25	11.31
Sep 25	11.31
Sep 25	11.22
Aug 25	11.22
Aug 25	11.22
Aug 25	11.07
Aug 25	10.89
Aug 25	10.92
Jul 25	10.54
Jul 25	10.95
Jul 25	10.95
Jul 25	10.81
Jun 25	15.58
Jun 25	15.58
Jun 25	15.58
Jun 25	15.58
May 25	13.71
May 25	13.71
May 25	13.71
May 25	13.71
May 25	14.64
Apr 25	12.77
Apr 25	12.6
Apr 25	12.6
Apr 25	14
Mar 25	12.77
Mar 25	12.85
Mar 25	10.73
Mar 25	11.44
Feb 25	11.59
Feb 25	11.59
Feb 25	10.73
Feb 25	10.73
Jan 25	11.08
Jan 25	11.08
Jan 25	10.22
Jan 25	10.81
Jan 25	10.81
Dec 24	7.16
Dec 24	6.74
Dec 24	6.39
Dec 24	6.28
Nov 24	6.92
Nov 24	6.47
Nov 24	6.34
Nov 24	7.27
Nov 24	6.66
Oct 24	6.31
Oct 24	7.56

Price to Book

HLTRF Price to Book by quarter
Period	Price to Book
Sep 26	1.5
Sep 26	1.41
Aug 26	1.47
Aug 26	1.46
Aug 26	1.48
Aug 26	1.59
Jul 26	1.59
Jul 26	1.6
Jul 26	1.64
Jul 26	1.64
Jul 26	1.6
Jun 26	1.61
Jun 26	1.61
Jun 26	1.6
Jun 26	1.6
May 26	1.66
May 26	1.66
May 26	1.74
May 26	1.74
May 26	1.75
Apr 26	1.73
Apr 26	1.72
Apr 26	1.63
Apr 26	1.52
Mar 26	1.53
Mar 26	1.71
Mar 26	1.71
Mar 26	1.71
Feb 26	1.71
Feb 26	1.71
Feb 26	1.71
Feb 26	1.71
Jan 26	1.71
Jan 26	1.71
Jan 26	1.71
Jan 26	1.71
Jan 26	1.74
Dec 25	1.64
Dec 25	1.63
Dec 25	1.63
Dec 25	1.65
Nov 25	1.65
Nov 25	1.65
Nov 25	1.65
Nov 25	1.91
Oct 25	1.91
Oct 25	1.91
Oct 25	1.91
Oct 25	1.91
Oct 25	1.81
Sep 25	1.81
Sep 25	1.82
Sep 25	1.82
Sep 25	1.81
Aug 25	1.81
Aug 25	1.81
Aug 25	1.78
Aug 25	1.76
Aug 25	1.76
Jul 25	1.7
Jul 25	1.77
Jul 25	1.77
Jul 25	1.74
Jun 25	1.63
Jun 25	1.63
Jun 25	1.63
Jun 25	1.63
May 25	1.43
May 25	1.43
May 25	1.43
May 25	1.43
May 25	1.53
Apr 25	1.34
Apr 25	1.32
Apr 25	1.32
Apr 25	1.47
Mar 25	1.3
Mar 25	1.31
Mar 25	1.09
Mar 25	1.17
Feb 25	1.18
Feb 25	1.18
Feb 25	1.09
Feb 25	1.09
Jan 25	1.13
Jan 25	1.13
Jan 25	1.04
Jan 25	1.1
Jan 25	1.1
Dec 24	1.04
Dec 24	0.97
Dec 24	0.92
Dec 24	0.91
Nov 24	1
Nov 24	0.94
Nov 24	0.92
Nov 24	1.05
Nov 24	0.96
Oct 24	0.91
Oct 24	1.09

No video analysis for this stock yet. Request one from our team.

News: HLTRF

marketbeat.com · 12 Aug 2026

HLS Therapeutics Q2 Earnings Call Highlights

HLS Therapeutics TSE: HLS reported second-quarter fiscal 2026 revenue growth as its cardiovascular portfolio expanded 25% year over year, led by continued gains for Vascepa and the first full quarter of sales for newly launched NILEMDO.

AI Analysis

HLS Therapeutics Inc.

Video analysis: HLTRF

News: HLTRF

HLS Therapeutics Q2 Earnings Call Highlights

Similar companies